Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 |
| Revenues | 8.8 | 1.0 |
| Revenue growth | 807.9% | |
| Cost of goods sold | 0.0 | 0.0 |
| Gross profit | 8.8 | 1.0 |
| Gross margin | 100.0% | 100.0% |
| Research and development | 33.9 | 18.2 |
| General and administrative | 12.8 | 5.0 |
| EBIT | -37.9 | -22.2 |
| EBIT margin | -432.0% | -2297.7% |
| Pre-tax income | -38.1 | -21.9 |
| Income taxes | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% |
| Net income | -43.0 | -25.9 |
| Net margin | -490.0% | -2673.4% |
| |
| Diluted EPS | ($3.17) | ($25.00) |
| Shares outstanding (diluted) | 13.6 | 1.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|